Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study.
Observational studies of switching from branded to generic formulations of the same drug substance often lack appropriate comparators for the subjects who switched. Three generic formulations were deemed equivalent to Concerta: an authorized generic (AG) identical except for external packaging, and...
Main Authors: | Daniel Fife, M Soledad Cepeda, Alan Baseman, Henry Richards, Peter Hu, H Lynn Starr, Anthony G Sena |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5831385?pdf=render |
Similar Items
-
Priapism Associated with MethylphenidateSR (Concerta) Withdrawal
by: J Gordon Millichap
Published: (2004-07-01) -
Concerta cf Ritalin Effects on Driving Performance
by: J Gordon Millichap
Published: (2004-03-01) -
Qualitative Analysis of Erythro-Methylphenidate Isomers Contained within Methylphenidate HCl Capsules using TLC
by: Nakai, Jodi S.
Published: (2005) -
Epileptic Seizure Following A Switch From Short-acting Methylphenidate to Long-acting Methylphenidate Treatment: A Case Report
by: Serkan Şahin, et al.
Published: (2019-11-01) -
Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
by: Sathis Kumar Dinakaran, et al.
Published: (2011-09-01)